Humira and Costochondritis - a phase IV clinical study of FDA data
Summary:
Costochondritis is found among people who take Humira, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Humira and have Costochondritis. It is created by eHealthMe based on reports of 606,284 people who have side effects when taking Humira from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
606,284 people reported to have side effects when taking Humira.
Among them, 131 people (0.02%) have Costochondritis.
What is Humira?
Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 608,927 Humira users for its effectiveness, alternative drugs and more.
What is Costochondritis?
Costochondritis (chest wall pain) is found to be associated with 946 drugs and 529 conditions by eHealthMe.
Number of Humira and Costochondritis reports submitted per year:
Time on Humira when people have Costochondritis *:
Gender of people who have Costochondritis when taking Humira*:
Age of people who have Costochondritis when taking Humira *:
Common drugs people take besides Humira *:
Common side effects people have besides Costochondritis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Humira and have Costochondritis?
Check whether Costochondritis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Related studies
Alternative drugs to, pros and cons of Humira:
- Humira (608,927 reports)
Costochondritis treatments and more:
- Costochondritis (2,535 reports)
COVID vaccines that are related to Costochondritis:
- Costochondritis in Moderna COVID Vaccine
- Costochondritis in Pfizer BioNTech Covid Vaccine
- Costochondritis in Johnson and Johnson Covid Vaccine
How severe was Costochondritis and when was it recovered:
Expand to all the drugs that have ingredients of adalimumab:
- Costochondritis and drugs with ingredients of adalimumab (116 reports)
Common drugs associated with Costochondritis:
- Ambien: 109 reports
- Aredia: 127 reports
- Aspirin: 152 reports
- Celebrex: 132 reports
- Enbrel: 110 reports
- Fosamax: 217 reports
- Humira: 131 reports
- Lipitor: 108 reports
- Methotrexate: 170 reports
- Prednisone: 207 reports
- Prevacid: 106 reports
- Prilosec: 133 reports
- Protonix: 114 reports
- Synthroid: 142 reports
- Vioxx: 246 reports
- Zometa: 146 reports
All the drugs that are associated with Costochondritis:
- Costochondritis (946 drugs)
Common conditions associated with Costochondritis:
- Osteoporosis: 178 reports
- Pain: 144 reports
- Pain exacerbated: 144 reports
- Pain management: 144 reports
- Pain relief by acupuncture: 144 reports
- Ra: 196 reports
- Rheumatoid arthritis: 196 reports
All the conditions that are associated with Costochondritis:
- Costochondritis (529 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clexane and Capecitabine drug interaction - a second ago
- Zosyn and Myositis - 13 seconds ago
- Omnipaque 140 and Chlorhexidine Gluconate drug interaction - 16 seconds ago
- Hytrin and Angioplasty - 16 seconds ago
- Breo Ellipta and Elocon drug interaction - 18 seconds ago